Feasibility and advantage of adding131I-MIBG to90Y-DOTATOC for treatment of patients with advanced stage neuroendocrine tumors
Bushnell, David L, Madsen, Mark T, O’cdorisio, Thomas, Menda, Yusuf, Muzahir, Saima, Ryan, Randi, O’dorisio, MVolume:
4
Language:
english
Journal:
EJNMMI Research
DOI:
10.1186/s13550-014-0038-2
Date:
December, 2014
File:
PDF, 638 KB
english, 2014